Qing FA pharmaceutical Industry insolvent sold 148 million Ke Lun pharmaceutical industry willing to be a sucker

What is the value of a drug company with a performance deficit, debt-ridden, insolvency, or even multiple lawsuits? The equity takeover announcement, released today (December 28), is the answer to the 002422, closing price of 143.20 yuan.　　The ailing drug company named Guangdong Qing FA Pharmaceutical Co., Ltd. (hereinafter referred to as Guangdong Qing FA), the Cologne pharmaceutical industry intends to use 24.3 million yuan to acquire its 100% stake, and also to pay 123.7 million yuan to help it repay huge debts. Insolvency incredibly sell 148 million ke Lun pharmaceutical industry notice, to 24.3 million yuan of the price to buy Guangdong Qing Fat 100% of the stake, and bear Guangdong Birthday as of December 31, 2010 including litigation,　　Arbitration, no more than 123.7 million yuan of all debts, the acquisition of the 148 million yuan to pay all the funds from the company's super raise funds. It's worth noting that the drug company, which has been in the industry for a long time, was a loss-laden, debt-ridden, insolvent firm with multiple debt lawsuits. Data show that Guangdong celebrated hair is a 1991 on the establishment of the old drug companies, registered capital of only 24.3 million yuan, the current shareholder only two, Guangdong Sanvi Bio-pharmaceutical group holding 70%, natural person Zhang Yu shares 30%. As of June 30 this year, the loss of 935,800 Yuan, the owner of the equity-97.07 million yuan, has been insolvent situation.　　In addition, Guangdong celebrates at least 4 lawsuits or arbitration disputes, and houses, land use rights, some equipment and bank accounts are mortgaged or frozen by the relevant courts. Why the Cologne pharmaceutical industry is willing to "a sucker" "Guangdong celebrates hair is a hot potato!" "A market person told the Daily economic news that the company is not only spending a huge sums of money to buy such an insolvent firm, but it is also facing an intricate debt lawsuit and whether there are hidden reefs."　　He further believes that the sale of some of the business is not cost-effective, the pharmaceutical industry has a willingness to "take a ride" suspicion, and the most willing to wait and see its natural is eager to get away from the Guangdong Qing hair shareholders and creditors. However, the pharmaceutical industry seems to have another plan, in its announcement, the Guangdong Qingfeng production of povidone iodine solution products in the southeast coastal region has a high profile, its own povidone iodine raw materials, povidone iodine solution agent production documents. After the acquisition is complete, the product can enrich the product line of the Ke Lun pharmaceutical industry.　　In addition, after the completion of the acquisition, Guangdong Qing Hair as the company's control of Guangdong Local enterprises, in favor of the company's products in Guangdong province to bid for drugs, expand the company's infusion products in Guangdong Province Sales scale, and can significantly reduce the sales of infusion products logistics costs.　　At the same time, the Cologne pharmaceutical industry is drawing up after the acquisition of the expansion of the transformation plan, initial plans to invest about 150 million yuan of capital, so that Guangdong celebrates 2012-2013 years annual production of plastic bottle packaging large infusion 300 million bottles, povidone iodine solution agent 20 million bottles, annual operating income of about 520 million yuan, net profit of about 65 million yuan. Industry catfish,Big Infusion Faucet ... Through great strides in mergers and acquisitions, firmly control their position in the industry. It can be said that after the listing of the heavily-held Cologne pharmaceutical industry, acquisition and merger expansion has become commonplace. However, some people in the industry believe that this time the acquisition of the drug industry in Cologne is questionable.